International evidence-based guidelines on POCUS for critically ill neonates and children were recently issued by the POCUS Working Group of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC).1 Although POCUS has experienced significant growth in clinical use by traditionally non-imaging based specialties, recent concerns from colleagues, administrators and regulatory agencies have emerged. In 2020, the European Society of Paediatric Radiology (ESPR) published a position paper on the use of Point-of-Care Ultrasound (POCUS) by non-radiology performers. In this position paper, multiple concerns were raised regarding translation of this technology to new practice environments. Current training platforms were described as a “gimmick,” and the practice itself is suggested to result in missed diagnosis, delayed therapeutics and increased costs for families and institutions.2 Similarly, the Emergency Care Research Institute (ECRI), a nonprofit organization designated as an Evidence-based Practice Center in the United States providing guidance for US healthcare regulatory agencies such the Agency for Healthcare Research and Quality (AHRQ) and the Joint Commission, in 2020 identified POCUS as #2 among the top 10 greatest technology hazards within healthcare. The ECRI stated that “safeguards for ensuring that POCUS users have the requisite training, experience, and skill have not kept pace with the speed of adoption. The lack of sufficient oversight increases the potential that patients will be adversely affected by problems associated with use, or lack of use, of the technology.”3 Thus safety commissions, regulatory agencies as well as our very own colleagues suggest that POCUS places providers, patients and institutions at varied risks of adverse outcomes.
The POCUS community response to these statements has been swift and pointed. Representatives from the European Society of Emergency Pediatrics (ESEP), the Ultrasound Section of the European Society for Emergency Medicine (EUSEM), and the Pediatric Emergency Medicine Point-of Care Ultrasound (P2) “respectfully disagree with the conclusions [of the ESPR statement], especially the need for further oversight from our radiology colleagues.”4 While the ESPR position statement recommens a well thought-out curriculum for each clinical specialty wishing to perform POCUS and lists European credentialing/certification methods for undergraduates, general radiology training and radiology subspecialisation, it should be noted that these are not requirements for licensing and performing pediatric ultrasound as a radiologist in Europe.2 The “need for credentialing non-radiologists who want to become involved in non-radiologist point-of-care US” should be balanced by what is expected of radiologists themselves.5 Similarly, a perspective published by adult and pediatric POCUS experts suggest that “if these statements [by the ECRI] are used to guide the governance of POCUS use in PICUs, the resulting policies may be overly restrictive of a practice that actually has several potential benefits” and that, within the ECRI report, “no objective data were presented” as a basis for concerns.6
Three publications review POCUS litigation, none of which found medicolegal cases from the use of POCUS.7–9 In fact, the only cases related to POCUS arose from its lack of use when the technology was available. Assessing medicolegal risk is a forward-thinking process to prevent harm, whether to patient, provider or institution. As ultrasound technology permeates our pediatric practice settings, we must listen to the voices of concern raised by traditional imaging specialists, our institutional administrators and local, national and international regulatory agencies. We suggest that listening to concerns and partnering with experienced providers, administrators and regulatory agencies will not only help to develop strategies towards risk reduction, but also result in a practice structure that improves provider performance and patient outcome. Discussion of safety and new technologies in medicine lend itself to concerns for potential litigation.
Frameworks for risk assessment exist across varied professional endeavors. Many of the quality and safety principles emerging in medicine are translated from practices in high-risk industries such as aviation and nuclear power.10–12 A leading group within the National Health Service (NHS) in England recently published a risk assessment framework (RAF) to standardize methods of prospectively evaluating risks associated with clinical practice.13 As clinicians, we recognize that there is a risk in all of our actions, and even risk in our inactions. Thus, the RAF provides a wholistic approach to identify, analyze, evaluate and manage risk in the clinical setting and determine its acceptability within a practice environment (Table 1). This manuscript discusses the RAF as it applies to POCUS in the varied international settings of our pediatric clinical practice.